{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:16:06Z","timestamp":1766157366280},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,9,12]],"date-time":"2009-09-12T00:00:00Z","timestamp":1252713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00702-009-0301-2","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T06:01:39Z","timestamp":1252648899000},"page":"1631-1634","source":"Crossref","is-referenced-by-count":11,"title":["Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases"],"prefix":"10.1007","volume":"116","author":[{"given":"Tibor","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Farsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edina","family":"Vitaszil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Barsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Gy\u00f6rke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Szirmai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kamondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,12]]},"reference":[{"key":"301_CR1","first-page":"515","volume":"16","author":"P Agarwal","year":"2003","unstructured":"Agarwal P, Frucht SJ (2003) Myoclonus. Curr Opin Neurol 16:515\u2013521","journal-title":"Curr Opin Neurol"},{"key":"301_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.09.005","volume":"63","author":"RG Beran","year":"2005","unstructured":"Beran RG, Berkovic SF, Black AB et al (2005) Efficacy of levetiracetam 1000\u20133000\u00a0mg\/day in patients with refractory partial-onset seizures: a multicenter, open label single-arm study. Epilepsy Res 63:1\u20139","journal-title":"Epilepsy Res"},{"key":"301_CR3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","volume":"69","author":"SF Berkovic","year":"2007","unstructured":"Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, The Levetiracetam N01057 Study Group (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69:1751\u20131760","journal-title":"Neurology"},{"key":"301_CR4","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ana.10570","volume":"54","author":"BF Boeve","year":"2003","unstructured":"Boeve BF, Lamg AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54:S15\u2013S19","journal-title":"Ann Neurol"},{"key":"301_CR5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000110193.78872.DD","volume":"62","author":"C Crest","year":"2004","unstructured":"Crest C, Dupont S, Leguern E et al (2004) Levetiracetam in progressive myoclonic epilepsy. An exploratory study in 9 patients. Neurology 62:640\u2013643","journal-title":"Neurology"},{"key":"301_CR6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00228-004-0842-0","volume":"60","author":"M D\u2019Amelio","year":"2005","unstructured":"D\u2019Amelio M, Callari G, Gammino M et al (2005) Levetiracetam in the treatment of vascular chorea: a case report. Eur J Clin Pharmacol 60:835\u2013836","journal-title":"Eur J Clin Pharmacol"},{"key":"301_CR7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.wnf.0000186648.93612.a5","volume":"28","author":"M Tommaso de","year":"2005","unstructured":"de Tommaso M, di Fruscolo O, Sciruicchio V et al (2005) Efficacy of levetiracetam in Huntington disease. Clin Neuropharmacol 28:280\u2013284","journal-title":"Clin Neuropharmacol"},{"key":"301_CR8","first-page":"13","volume":"89","author":"S Fahn","year":"2002","unstructured":"Fahn S (2002) Overview, history, and classification of myoclonus. Adv Neurol 89:13\u201317","journal-title":"Adv Neurol"},{"issue":"Suppl 3","key":"301_CR9","first-page":"107","volume":"15","author":"S Frucht","year":"2000","unstructured":"Frucht S, Leurgans S, Hallet M et al (2000) The Unified Myoclonus Rating Scale (UMRS): a statistically validated clinical rating instrument for evaluating patients with myoclonus. Mov Disord 15(Suppl 3):107","journal-title":"Mov Disord"},{"key":"301_CR10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.1995.tb00172.x","volume":"2","author":"M Grisoli","year":"1995","unstructured":"Grisoli M, Fetoni V, Savoiardo M et al (1995) MRI in corticobasal degeneration. Eur J Neurol 2:547\u2013552","journal-title":"Eur J Neurol"},{"key":"301_CR11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/mds.10535","volume":"18","author":"P Grosse","year":"2003","unstructured":"Grosse P, K\u00fchn A, Cordivari C, Brown P (2003) Coherence analysis in the myoclonus of corticobasal degeneration. Mov Disord 18:1345\u20131350","journal-title":"Mov Disord"},{"key":"301_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","volume":"73","author":"SC Keswani","year":"2002","unstructured":"Keswani SC, Kossoff EH, Krauss GL et al (2002) Amelioration of spinal myoclonus with levetiracetam. J Neurol Neurosurg Psychiatry 73:457\u2013458","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"301_CR13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.55.7.957","volume":"55","author":"K Kompoliti","year":"1998","unstructured":"Kompoliti K, Goetz CG, Boeve BF et al (1998) Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 55:957\u2013961","journal-title":"Arch Neurol"},{"key":"301_CR14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.56.3.411","volume":"56","author":"GL Krauss","year":"2001","unstructured":"Krauss GL, Bergin MB, Kramer RE et al (2001) Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 56:411\u2013412","journal-title":"Neurology"},{"key":"301_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ et al (2003) SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467\u2013486","journal-title":"Mov Disord"},{"key":"301_CR16","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracteam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.WNF.0000220814.48360.F4","volume":"29","author":"KE Lyons","year":"2006","unstructured":"Lyons KE, Pahwa R (2006) Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia. Clin Neuropharmacol 29:148\u2013153","journal-title":"Clin Neuropharmacol"},{"key":"301_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.2000.0689","volume":"42","author":"DG Margineanu","year":"2000","unstructured":"Margineanu DG, Klitgaard H (2000) Inhibition of neuronal hypersynchrony in\u00a0vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 42:281\u2013285","journal-title":"Pharmacol Res"},{"key":"301_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.WNF.0000228807.49044.7D","volume":"29","author":"G Meco","year":"2006","unstructured":"Meco G, Fabrizio E, Epifanio A et al (2006) Levetiracetam in tardive dyskinesia. Clin Neuropharmacol 29:265\u2013268","journal-title":"Clin Neuropharmacol"},{"key":"301_CR20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410430507","volume":"43","author":"T Mima","year":"1998","unstructured":"Mima T, Nagamini T, Ikeda A et al (1998) Pathogenesis of cortical myoclonus studied by magnetoencephalography. Ann Neurol 43:598\u2013607","journal-title":"Ann Neurol"},{"key":"301_CR21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","volume":"40","author":"DE Riley","year":"1990","unstructured":"Riley DE, Lang AE, Lewis A et al (1990) Cortical-basal ganglionic degeneration. Neurology 40:1203\u20131212","journal-title":"Neurology"},{"key":"301_CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/brain\/114.1.541","volume":"114","author":"GV Sawle","year":"1991","unstructured":"Sawle GV, Brooks DJ, Marsden CD et al (1991) Corticobasal degeneration: a unique pattern of regional cortical oxygen metabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 114:541\u2013556","journal-title":"Brain"},{"key":"301_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0013-4694(75)90046-2","volume":"36","author":"H Shibasaki","year":"1975","unstructured":"Shibasaki H, Kuroiwa Y (1975) Electroencephalographic correlates of myoclonus. Electroencephalogr Clin Neurophysiol 36:455\u2013463","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"301_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0967-5868(95)90053-5","volume":"2","author":"E Storey","year":"1995","unstructured":"Storey E, Lichtenstein M, Desmond P et al (1995) Clinical features and SPECT scanning in presumed corticobasal ganglionic degeneration. J Clin Neurosci 2:321\u2013328","journal-title":"J Clin Neurosci"},{"key":"301_CR25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.20530","volume":"20","author":"P Striano","year":"2005","unstructured":"Striano P, Manganelli F, Boccella P et al (2005) Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 20:1610\u20131614","journal-title":"Mov Disord"},{"key":"301_CR26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/117.5.1197","volume":"117","author":"PD Thompson","year":"1994","unstructured":"Thompson PD, Day BL, Rothwell JC et al (1994) The myoclonus in corticobasal degeneration. Brain 117:1197\u20131207","journal-title":"Brain"},{"key":"301_CR27","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1016\/S1353-8020(08)70027-0","volume":"13","author":"PM Wadia","year":"2007","unstructured":"Wadia PM, Lang AE (2007) The many faces of corticobasal degeneration. Parkinsonism Relat Disord 13:S336\u2013S340","journal-title":"Parkinsonism Relat Disord"},{"key":"301_CR28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mds.20233","volume":"19","author":"TA Zesiewicz","year":"2004","unstructured":"Zesiewicz TA, Louis ED, Sulivan KL et al (2004) Substantial improvement in a Meige\u2019s syndrome patient with levetiracteam treatment. Mov Disord 19:1518\u20131521","journal-title":"Mov Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-009-0301-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0301-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:25:16Z","timestamp":1559089516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-009-0301-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s00702-009-0301-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,12]]}}}